• Open Account

Gujarat Themis Biosyn Ltd

Small Cap  | Pharmaceuticals
₹ 363.5 -4.45(-1.21%)
Last updated: 09-Oct-2026 , 15:59:50
Gujarat Themis Biosyn Ltd Price Today Gujarat Themis Biosyn Ltd share price is ₹363.5 as on 09-Oct-2026, Down 1.21% from the previous close of ₹367.95. The stock has traded between ₹373.6 and ₹359.6 today, against a 52-week range of ₹225.05 to ₹479. Over the past year the stock is Up 112.84% range. Market capitalisation stands at ₹4942.51 crore.

Gujarat Themis Biosyn Ltd Live Price Chart

Performance

Low: ₹359.6 High: 373.6
Previous Close ₹ 367.95
High ₹ 373.6
Volume 391458
52W Range ₹ 225.05 - ₹ 479
Open ₹ 368.05
Low ₹ 359.6
Market Cap ₹ 4942.51 Cr

Gujarat Themis Biosyn Ltd Technicals

Current Price
₹ 363.5 -4.45 (-1.21%)
EMASMA
20 Day ₹ 397.074
50 Day ₹ 395.101
100 Day ₹ 384.981
200 Day ₹ 373.571
20 Day ₹ 406.025
50 Day ₹ 392.605
100 Day ₹ 386.995
200 Day ₹ 361.958

Gujarat Themis Biosyn Ltd Fundamentals

ROCE 14.467
P/E Ratio 97.130
P/B Ratio 4.560
Industry P/E 4.560
Debt to Equity 49.246
ROE 16.222
EPS 3.740
Dividend Yield 0.150
Book Value 79.735
Face Value 1.000

Gujarat Themis Biosyn Ltd Financials

Particulars Y202603 Y202503 Y202403 Y202303 Y202203
Total Revenue 168.2509 152.4745 174.1876 154.9728 118.904
Total Expenses 106.1609 86.9366 94.8533 77.508 59.8695
Profit After Tax 46.6815 48.7717 59.1632 57.9688 43.6242

Gujarat Themis Biosyn Ltd Shareholding Pattern

Promoter Holdings 59.329 %
FIIs 4.932 %
DIIs 4.133 %
MutualFund 9.657 %
Retail 16.430 %
Others - 5.520 %

About Gujarat Themis Biosyn Ltd

Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, Company was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corp., South Korea, brought in technology and finance for running GTBL. During 1995-96 the paid-up share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interest term loan. During the year 2019-20, installed capacity of Rifamysin-S was increased to 90 million tones per annum and expansion of rifampicin was achieved to the maximum capacity of 120 million tones per annum. It also commen ...

Similar Stocks

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals ₹ 40.59
+0.32 (+0.79%)
Amrutanjan Health Care Ltd Pharmaceuticals ₹ 508.90
+5.85 (+1.16%)
Astrazeneca Pharma India Ltd Pharmaceuticals ₹ 5,837.00
+117.5 (+2.05%)
Bliss GVS Pharma Ltd Pharmaceuticals ₹ 655.95
-11.75 (-1.76%)
Abbott India Ltd Pharmaceuticals ₹ 26,000.00
+420 (+1.64%)
Cipla Ltd Pharmaceuticals ₹ 1,301.00
-5.8 (-0.44%)

FAQs on Gujarat Themis Biosyn Ltd

1. Can I buy Gujarat Themis Biosyn Ltd from PL Capital? ›

Yes, you can invest in Gujarat Themis Biosyn Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Gujarat Themis Biosyn Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Gujarat Themis Biosyn Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Gujarat Themis Biosyn Ltd pay dividends? ›

Yes, Gujarat Themis Biosyn Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Gujarat Themis Biosyn Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Gujarat Themis Biosyn Ltd ? ›

As of 09-Oct-2026 , 15:59:50 the share price for Gujarat Themis Biosyn Ltd. is ₹ 363.5 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Gujarat Themis Biosyn Ltd ? ›

The 52-week high and low of Gujarat Themis Biosyn Ltd share price is ₹ 225.05 - ₹ 479 as of 09-Oct-2026 , 15:59:50 .

5. What is the market capitalisation of Gujarat Themis Biosyn Ltd? ›

Market capitalisation of Gujarat Themis Biosyn Ltd is ₹4942.51Cr as of 09-Oct-2026.

6. What is the current P/E ratio of Gujarat Themis Biosyn Ltd? ›

The P/E (price-to-earnings) ratio of Gujarat Themis Biosyn Ltd is 97.130.

7. What is the current P/B ratio of Gujarat Themis Biosyn Ltd? ›

The P/B (price-to-book) ratio of Gujarat Themis Biosyn Ltd is 4.560.

8. What is the shareholding pattern of Gujarat Themis Biosyn Ltd? ›

As of 09-Oct-2026, promoters hold 59.329%, foreign institutional investors hold 4.932%, domestic institutional investors hold 4.133%, and the public holds 16.430%.

9. What is the 1-year return of Gujarat Themis Biosyn Ltd? ›

The 1-year return of Gujarat Themis Biosyn Ltd is + 112.84%.
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP

Start SIP in Gujarat Themis Biosyn Ltd

Invest systematically in stocks with the
PL Capital app

Get the App
Start SIP mobile app preview
App QR Code

Download the PL Capital App

Open Demat Account
×
I consent to receive calls/messages from PL